@FierceBiotech: Merck KGaA says big M&A could jump-start stilted pipeline. Story | Follow @FierceBiotech
@JohnCFierce: Best case scenario for Lemtrada: FDA OKs for a very limited group of desperate patients. | Follow @JohnCFierce
@DamianFierce: Sanofi gets mixed FDA blessing for MS drug Lemtrada. More | Follow @DamianFierce
@EmilyMFierce: Tuberculosis R&D dropped by $30.4 million in 2012 compared with 2011. Report | Follow @EmilyMFierce
> VC mainstay New Enterprise Associates has opened an office in Cambridge, MA's Kendall Square, a biotech hub that also houses Biogen Idec ($BIIB) and Novartis ($NVS). Story
> Breakout Labs, founded by billionaire Peter Thiel, is backing biotech startups Pareto Biotechnologies and CytoVale. News
> Johnson & Johnson ($JNJ) and Pharmacyclics ($PCYC) have priced their just-approved cancer drug Imbruvica (ibrutinib) at $130,000 a year. Article
@FierceMedDev: Analysts: Volcano could be an M&A fit for Abbott, Medtronic. More | Follow @FierceMedDev
@MarkHFierce: Inspired by a wine cork removal device, an Argentinian mechanic developed a surgical tool to aid difficult births. Story | Follow @MarkHFierce
@MichaelGFierce: From FierceDrugDelivery: DNA-delivering patch spurs bone growth. Piece | Follow @MichaelGFierce
> Tandem banks $120M in topped-out IPO, stirring med tech market hopes. Article
> Biomet hit with metal hip lawsuit in Canada. More
Pharma News
@FiercePharma: Tuesday's top news: Breakthrough hep C meds aren't yet for sale, but critics already taking aim at prices. Story | Follow @FiercePharma
@EricPFierce: Actavis takes aim at North Carolina plant, 310 jobs, as it looks to cut costs. More | Follow @EricPFierce
@CarlyHFierce: CFR chief angles for meeting with Adcock Ingram after top investor nixes $1.3B deal. Story | Follow @CarlyHFierce
> Novartis, Novavax tout ability to quickly whip up pandemic flu vaccines. News
> Merck KGaA hikes forecast, eyes deals as cost cuts keep delivering. More
> Supreme Court nixes Teva's last-ditch bid to block Copaxone generics. Article
Vaccines News
> Agenus, Sanofi-NIH collaboration race to develop genital herpes vaccine. Story
> Novartis to sell first piece of vaccine unit in $1.7B deal. Article
> Polio outbreak sparks fears refugees will carry virus to Europe. Report
> Dendreon to lay off more staff as Provenge disappoints. Again. More
> Novavax presents positive Phase I data for H7N9 vaccine. Story
> U.K. adds schools to flu data-gathering project. Item
Pharma Manufacturing News
> Track-and-trace bill may be finished this week. Article
> Lilly to invest $700M in plant expansions. More
> Sandoz pulls some TB drugs in India. Report
> Dendreon hopes manufacturing can save the day. Story
> FDA red-flags dangerous counterfeit ED product. Article
> New manufacturing processes could produce bird flu vax ASAP. Item